| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5605674 | KINDEVA | Medicinal aerosol formulations |
Feb, 2014
(10 years ago) | |
| US5775321 | KINDEVA | Seal configuration for aerosol canister |
Jul, 2015
(8 years ago) | |
| US6006745 | KINDEVA | Device for delivering an aerosol |
Dec, 2016
(7 years ago) | |
Proventil-Hfa is owned by Kindeva.
Proventil-Hfa contains Albuterol Sulfate.
Proventil-Hfa has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Proventil-Hfa are:
- US5605674
- US5775321
- US6006745
Proventil-Hfa was authorised for market use on 15 August, 1996.
Proventil-Hfa is available in aerosol, metered;inhalation dosage forms.
The generics of Proventil-Hfa are possible to be released after 28 December, 2016.
Drugs and Companies using ALBUTEROL SULFATE ingredient
Market Authorisation Date: 15 August, 1996
Treatment: NA
Dosage: AEROSOL, METERED;INHALATION
How can I launch a generic of PROVENTIL-HFA before it's drug patent expiration?
More Information on Dosage
PROVENTIL-HFA family patents
